Pricing Log in Create free account

AgomAb Therapeutics NV (AGMB) vs Adherex Technologies Inc. (FENC)

AgomAb Therapeutics NV and Adherex Technologies Inc. are both Biotechnology companies. AgomAb Therapeutics NV and Adherex Technologies Inc. are of similar size ($343.3M and $329.3M). Across the 7 metrics below, AgomAb Therapeutics NV leads on 6 and Adherex Technologies Inc. on 1.

Valuation

Metric AGMB FENC Biotechnology median
P/E — n/m 10.60
P/S — 5.77 9.40
P/B n/m 8.05 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 5.38 9.02
Earnings yield — (1.25%) (32.88%)
Free cash flow yield 0.00% (0.60%) (23.13%)

Profitability

Metric AGMB FENC Biotechnology median
Gross margin — 93.73% 68.51%
Operating margin — (1.90%) 0.00%
Net margin — (5.49%) 0.00%
Free cash flow margin 0.00% (3.44%) 0.00%
Return on equity — (18.58%) (51.96%)
Return on assets — (5.39%) (46.06%)
Return on invested capital 0.00% (58.89%) 0.00%

Growth

Metric AGMB FENC Biotechnology median
Revenue growth (TTM) — 77.83% 6.76%
EPS growth (last fiscal year) (39.80%) (2,087.50%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric AGMB FENC Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 12.88 5.85 4.97
Net debt to EBITDA 1.96 6.02 1.01

Dividend

Metric AGMB FENC Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AGMB FENC Biotechnology median
Market cap 343.27m 329.29m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack